CRAC Channel Deficiency in Immunity to Infection
CRAC Channel Deficiency in Immunity to Infection
批准号:
9918240
负责人:
STEFAN FESKE
金额:
$54.13万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-06-01 至 2023-04-30
关键词:
AcuteAddressAnemiaAntibody-mediated protectionAutoantibodiesAutoimmune hemolytic anemiaAutoimmunityB-LymphocytesBacteriaBacterial InfectionsBenefits and RisksBook ChaptersCD8-Positive T-LymphocytesCalciumCalcium ChannelCandida albicansCell Differentiation processCell membraneCell physiologyCellsCellular ImmunityChronicConflict (Psychology)DataDefectDendritic CellsDevelopmentDiseaseEctodermal DysplasiaErythrocytesFunctional disorderGenesGenus MycobacteriumGoalsHelper-Inducer T-LymphocyteHomologous GeneHumanHumoral ImmunitiesImmuneImmune responseImmune systemImmunityImmunologic Deficiency SyndromesImpairmentIn VitroInfectionInflammationInheritedInnate Immune ResponseLinkLymphoidMediatingMemoryMetabolicMetabolismMolecularMusMuscle hypotoniaMutationMycosesMyelogenousNamesNatural ImmunityPaperPatientsPharmaceutical PreparationsPhysiologicalPredispositionProductionProteinsPublishingRare DiseasesRegulationRegulatory T-LymphocyteResearchRiskRoleSTIM1 geneSamplingSourceStaphylococcus aureusStreptococcus pneumoniaeSweat GlandsSymptomsSyndromeT-LymphocyteTherapeuticThymus GlandTooth structureVirusVirus Diseasesadaptive immunityarmcell mediated immune responsechronic infectioncongenital immunodeficiencyfightingfungusgenetic analysisimmune functionimmune self tolerancein vivoinsightmacrophageneutrophilnovel therapeuticspathogenpathogenic bacteriapathogenic funguspathogenic virusprevent
中文摘要
摘要
我们研究的目标是了解免疫系统细胞中钙离子内流缺陷是如何引起的。
免疫缺陷患者钙离子内流调控基因的遗传性突变。由于同样的原因
患者还患有由抗红细胞自身抗体引起的贫血,这是我们的第二个目标
研究是为了了解钙离子内流是如何维持免疫自我耐受并防止
自身免疫力。我们的中心假设是,调节细胞内钙内流的CRAC通道
膜,是免疫的先天和适应性臂中不同细胞发挥功能所必需的
提供对感染的免疫力并防止自身免疫的系统。CRAC渠道是主要的来源
钙离子在大多数免疫细胞中内流。它们由通道蛋白ORAI1形成,并由
STIM1和STIM2。我们已经确定了第一批ORAI1和STIM1基因突变的患者
来自一种我们称为CRAC通道病的疾病,这种疾病的特征是免疫缺陷、自身免疫性和
几个非免疫性缺陷。因为CRAC通道病是一种罕见的疾病,患者样本
有限的,我们产生了T细胞中缺乏CRAC通道的小鼠。通过研究这些细胞的免疫反应
通过在CRAC经络病患者样本中验证关键结果,我们已经能够
明确CRAC通道在T细胞介导的免疫反应中的关键作用,特别是对细胞和
抗体介导的感染免疫,并在慢性感染期间限制免疫反应,这将
否则会引起有害的炎症。然而,我们仍远未完全了解CRAC是如何
渠道调节对感染的免疫力。除了T细胞,CRAC通道还可能调节先天免疫
树突状细胞和中性粒细胞介导的应答。到目前为止,研究得出了相互矛盾的数据
CRAC通道是先天免疫细胞功能所必需的,它们对感染的先天免疫作用有
没有被研究过。除了对感染的免疫外,CRAC通道对于免疫自我耐受也是必不可少的
通过控制调节性T细胞的发育,抑制其他免疫细胞的功能和
从而防止自身免疫。CRAC通道缺陷患者的Treg细胞较少,这可能解释了
他们的自身免疫力。CRAC通道如何控制Treg细胞的功能和防止自身免疫
明白了。针对这些问题,我们提出了以下三个具体目标:(1)我们将分析
遗传缺陷患者ORAI1和STIM1基因了解CRAC通道在免疫中的作用
CRAC通道的功能和分子调控。(2)我们会决定是否需要CRAC频道
用于树突状细胞和中性粒细胞的先天免疫反应,以对抗细菌和真菌感染。(3)我们
将确定CRAC通道如何控制调节性T细胞功能和防止自身免疫,特别是
自身免疫性溶血性贫血,通过研究CRAC通道缺陷小鼠和患者。我们的研究将
提供CRAC渠道如何调节对感染的免疫和防止自身免疫的基本见解。
英文摘要
Summary
The goal of our research is to understand how defects in calcium influx in cells of the immune system cause
immunodeficiency in patients with inherited mutations in genes regulating calcium influx. Since the same
patients also suffer from anemia caused by autoantibodies against red blood cells, a second goal of our
research is to understand how calcium influx maintains immunological self-tolerance and prevents
autoimmunity. Our central hypothesis is that CRAC channels, which mediate calcium influx across the cell
membrane, are required for the function of different cells in the innate and adaptive arms of the immune
system that provide immunity to infection and prevent autoimmunity. CRAC channels are the main source of
calcium influx in most immune cells. They are formed by the channel protein ORAI1 and are activated by
STIM1 and STIM2. We have identified the first patients with mutations in ORAI1 and STIM1 genes who suffer
from a disease we called CRAC channelopathy that is characterized by immunodeficiency, autoimmunity, and
several non-immunological defects. Because CRAC channelopathy is a rare disease and patient samples are
limited, we generated mice that lack CRAC channels in T cells. By investigating immune responses in these
mice and by validating key results in samples of patients with CRAC channelopathy, we have been able to
define a critical role of CRAC channels in T cell-mediated immune responses, in particular for cellular and
antibody-mediated immunity to infection and for limiting immune responses during chronic infection that would
otherwise cause harmful inflammation. However, we are still far from having a complete picture of how CRAC
channels regulate immunity to infection. Beyond T cells, CRAC channels may also regulate innate immune
responses mediated by dendritic cells and neutrophils. Studies so far have yielded conflicting data whether
CRAC channels are required for innate immune cell function, and their role for innate immunity to infection has
not been studied. Besides immunity to infection, CRAC channels are essential for immunological self-tolerance
by controlling the development of regulatory T cells, which suppress the function of other immune cells and
thereby prevent autoimmunity. CRAC channel-deficient patients have fewer Treg cells, potentially explaining
their autoimmunity. How CRAC channels control the function of Treg cells and prevent autoimmunity is not
understood. To address these questions, we propose the following three specific aims: (1) We will analyze
inherited defects in ORAI1 and STIM1 genes of patients to understand the role of CRAC channels for immune
function and the molecular regulation of CRAC channels. (2) We will determine if CRAC channels are required
for innate immune responses by dendritic cells and neutrophils to fight bacterial and fungal infections. (3) We
will determine how CRAC channels control regulatory T cell function and prevent autoimmunity, in particular
autoimmune hemolytic anemia, by studying CRAC channel-deficient mice and patients. Our studies will
provide fundamental insights how CRAC channels regulate immunity to infection and prevent autoimmunity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Ca2+ signaling via SOCE in the pathogenesis of Sjögren’s syndrome
-
批准号:10153457
-
项目类别:
-
资助金额:$53.17万
-
财政年份:2019
-
负责人:STEFAN FESKE
-
依托单位:
Ca2+ signaling via SOCE in the pathogenesis of Sjögren’s syndrome
-
批准号:9980846
-
项目类别:
-
资助金额:$53.41万
-
财政年份:2019
-
负责人:STEFAN FESKE
-
依托单位:
Ca2+ signaling via SOCE in the pathogenesis of Sjögren’s syndrome
-
批准号:10626980
-
项目类别:
-
资助金额:$52.67万
-
财政年份:2019
-
负责人:STEFAN FESKE
-
依托单位:
Ca2+ signaling via SOCE in the pathogenesis of Sjögren’s syndrome
-
批准号:10392382
-
项目类别:
-
资助金额:$52.71万
-
财政年份:2019
-
负责人:STEFAN FESKE
-
依托单位:
Calcium channel CACNB1 in T cell function and immunity
-
批准号:9811165
-
项目类别:
-
资助金额:$16.95万
-
财政年份:2019
-
负责人:STEFAN FESKE
-
依托单位:
Regulation of encephalitogenic T cells by CRAC channels
-
批准号:10461826
-
项目类别:
-
资助金额:$48.93万
-
财政年份:2018
-
负责人:STEFAN FESKE
-
依托单位:
Regulation of encephalitogenic T cells by CRAC channels
-
批准号:9981624
-
项目类别:
-
资助金额:$48.27万
-
财政年份:2018
-
负责人:STEFAN FESKE
-
依托单位:
Regulation of encephalitogenic T cells by CRAC channels
-
批准号:10238856
-
项目类别:
-
资助金额:$48.87万
-
财政年份:2018
-
负责人:STEFAN FESKE
-
依托单位:
Regulation of Follicular T cell Responses in the Lung by Ion Channels
-
批准号:9765152
-
项目类别:
-
资助金额:$47.46万
-
财政年份:2017
-
负责人:STEFAN FESKE
-
依托单位:
Regulation of Follicular T cell Responses in the Lung by Ion Channels
-
批准号:9444252
-
项目类别:
-
资助金额:$50.55万
-
财政年份:2017
-
负责人:STEFAN FESKE
-
依托单位:
Identifying Novel Ion Channels Regulating T cell Function
-
批准号:9297218
-
项目类别:
-
资助金额:$21.19万
-
财政年份:2016
-
负责人:STEFAN FESKE
-
依托单位:
Identifying Novel Ion Channels Regulating T cell Function
-
批准号:9165869
-
项目类别:
-
资助金额:$25.43万
-
财政年份:2016
-
负责人:STEFAN FESKE
-
依托单位:
Modulation of ORAI2 and ORAI3 Calcium Channels
-
批准号:9181053
-
项目类别:
-
资助金额:$25.43万
-
财政年份:2016
-
负责人:STEFAN FESKE
-
依托单位:
FASEB SRC on Calcium and Cell Function
-
批准号:9121418
-
项目类别:
-
资助金额:$0.8万
-
财政年份:2016
-
负责人:STEFAN FESKE
-
依托单位:
CRAC Channel Deficiency in Immunity to Infection
-
批准号:8820394
-
项目类别:
-
资助金额:$8.95万
-
财政年份:2014
-
负责人:STEFAN FESKE
-
依托单位:
CRAC Channel Deficiency in Immunity to Infection
-
批准号:8664577
-
项目类别:
-
资助金额:$45.69万
-
财政年份:2013
-
负责人:STEFAN FESKE
-
依托单位:
CRAC Channel Deficiency in Immunity to Infection
-
批准号:8659340
-
项目类别:
-
资助金额:$48.6万
-
财政年份:2012
-
负责人:STEFAN FESKE
-
依托单位:
CRAC Channel Deficiency in Immunity to Infection
-
批准号:9063465
-
项目类别:
-
资助金额:$48.6万
-
财政年份:2012
-
负责人:STEFAN FESKE
-
依托单位:
CRAC Channel Deficiency in Immunity to Infection
-
批准号:10395936
-
项目类别:
-
资助金额:$54.13万
-
财政年份:2012
-
负责人:STEFAN FESKE
-
依托单位:
CRAC Channel Deficiency in Immunity to Infection
-
批准号:9602202
-
项目类别:
-
资助金额:$53.62万
-
财政年份:2012
-
负责人:STEFAN FESKE
-
依托单位:
海外基金